ANRO NYSE · Healthcare · FY 2025-12-31

Alto Neuroscience, Inc.

0.07.314.621.929.2ABVfair 4.73buy ≤ 1.18EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 27.07 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
27.070 USD
Market cap
864.2M USD
P / B
5.72
P / E
EPS
-2.190
DPS / yield
(0.0%)
NAV / share
4.735
Graham number
Z'' score
4.87
Piotroski F
2 / 9
Beneish M
ROIC vs WACC
vs 11.4%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.